Risk Factors for Isoniazid Hepatotoxicity in Children With Latent TB and TB: Difference From Adults

被引:13
作者
Devrim, Ilker [1 ]
Olukman, Oezguer [1 ]
Can, Demet [1 ]
Dizdarer, Ceyhun [1 ]
机构
[1] Behcet Uz Childrens Hosp, Pediat Infect Dis Unit, TR-9035210 Izmir, Turkey
关键词
D O I
10.1378/chest.09-2120
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:737 / 738
页数:2
相关论文
共 5 条
[1]   Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection - A 7-year evaluation from a public health tuberculosis clinic [J].
Fountain, FF ;
Tolley, E ;
Chrisman, CR ;
Self, TH .
CHEST, 2005, 128 (01) :116-123
[2]   Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients [J].
Ohkawa, K ;
Hashiguchi, M ;
Ohno, K ;
Kiuchi, C ;
Takahashi, S ;
Kondo, S ;
Echizen, H ;
Ogata, H .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (02) :220-226
[3]   Risk factors for hepatotoxicity from antituberculosis drugs: A case-control study [J].
Pande, JN ;
Singh, SPN ;
Khilnani, GC ;
Khilnani, S ;
Tandon, RK .
THORAX, 1996, 51 (02) :132-136
[4]  
WHO, 1992, INT MON ADV REACT DR, DOI 10.2307/30133069
[5]   Isoniazid-related hepatic failure in children: A survey of liver transplantation centers [J].
Wu, Steven S. ;
Chao, Catherine S. ;
Vargas, Jorge H. ;
Sharp, Harvey L. ;
Martin, Martin G. ;
McDiarmid, Sue V. ;
Sinatra, Frank R. ;
Ament, Marvin E. .
TRANSPLANTATION, 2007, 84 (02) :173-179